Back
Greek Organisation of Football Prognostics SA Vs. Akero Therapeutics Industry Stock Comparison
Buy
57
GOFPY
Greek Organisation of Football Prognostics SA
Last Price:
$10.85
Seasonality Move:
-2.7%
Buy
66
AKRO
Akero Therapeutics
Last Price:
$54.69
Seasonality Move:
26.74%
Buy
57
Greek Organisation of Football Prognostics SA (GOFPY)
is a Buy
Is Greek Organisation of Football Prognostics SA a Buy, Sell or Hold?
-
The current Greek Organisation of Football Prognostics SA [GOFPY] share price is $10.94. The Score for GOFPY is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
GOFPY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.71. The Score for AKRO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GOFPY Stock Price Chart
What is Greek Organisation of Football Prognostics SA's stock price today?
-
The Greek Organisation of Football Prognostics SA share price today is $10.94The current trend is moderately bearish and GOFPY is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
GOFPY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 47.79 | Sell |
Chaikin Money Flow: | 6282 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.25 | Buy |
Relative Strength Index (14 RSI): | 71.1 | Buy |
Chaikin Money Flow: | 33208 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.6 - 51.14) | Buy |
Bollinger Bands (100): | (35.32 - 51.52) | Buy |
GOFPY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11 | Sell |
20-day SMA: | 11.23 | Sell |
50-day SMA: | 10.85 | Buy |
200-day SMA: | 9.18 | Buy |
8-day EMA: | 10.98 | Sell |
20-day EMA: | 11.09 | Sell |
50-day EMA: | 10.76 | Buy |
200-day EMA: | 9.53 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.99 | Buy |
20-day SMA: | 46.75 | Buy |
50-day SMA: | 42.7 | Buy |
200-day SMA: | 36.23 | Buy |
8-day EMA: | 52.06 | Buy |
20-day EMA: | 48.42 | Buy |
50-day EMA: | 44.97 | Buy |
200-day EMA: | 37.92 | Buy |
Greek Organisation of Football Prognostics SA Earnings Growth & GOFPY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Greek Organisation of Football Prognostics SA Technical Analysis
May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |